NCT06502015View on ClinicalTrials.gov

Biomarkers in Autoimmune Disease of Nervous System

RecruitingOBSERVATIONAL
Enrollment

50,000

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Autoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum DisorderMultiple SclerosisGuillain-Barre SyndromeAcute Disseminated EncephalomyelitisAutoimmune EncephalitisStiff-Person SyndromeMyasthenia GravisChronic Inflammatory Demyelinating PolyradiculoneuropathyIdiopathic Inflammatory MyopathiesAutoimmune Diseases
Interventions
DIAGNOSTIC_TEST

biomaker levels

this study will discover and validate novel biomarkers (including blood, feces, bone marrow and lymph nodes etc al) of various neurological autoimmune diseases

Trial Locations (1)

430030

RECRUITING

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER